메뉴 건너뛰기




Volumn 36, Issue 10, 2005, Pages 925-926

Allogeneic BMT followed by substrate reduction therapy in a child with subacute Tay-Sachs disease [5]

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE A; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MIGLUSTAT; THYMOCYTE ANTIBODY; VALPROIC ACID;

EID: 27844543404     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705155     Document Type: Letter
Times cited : (39)

References (6)
  • 3
    • 0035232879 scopus 로고    scopus 로고
    • Future perspectives for Tay-Sachs disease
    • Desnick RJ, Kaback MM. Future perspectives for Tay-Sachs disease. Adv Genet 2001; 44: 349-356.
    • (2001) Adv. Genet. , vol.44 , pp. 349-356
    • Desnick, R.J.1    Kaback, M.M.2
  • 4
    • 0029634283 scopus 로고
    • Allogeneic bone marrow transplantation for lysosomal storage diseases
    • The European group for bone marrow transplantation
    • Hoogerbrugge PM, Brouwer OF, Bordigoni P et al. Allogeneic bone marrow transplantation for lysosomal storage diseases. The European group for bone marrow transplantation. Lancet 1995; 345: 1398-1402.
    • (1995) Lancet , vol.345 , pp. 1398-1402
    • Hoogerbrugge, P.M.1    Brouwer, O.F.2    Bordigoni, P.3
  • 6
    • 0030937840 scopus 로고    scopus 로고
    • Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyl-deoxynojirimycin
    • Platt FM, Neises GR, Reinkensmeier G et al. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyl-deoxynojirimycin. Science 1997; 276: 428-431.
    • (1997) Science , vol.276 , pp. 428-431
    • Platt, F.M.1    Neises, G.R.2    Reinkensmeier, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.